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Non-communicable diseases in sub-Saharan 
Africa: a scoping review of large cohort studies
Background Non-communicable diseases (NCDs) cause a large and grow-
ing burden of morbidity and mortality in sub-Saharan Africa. Prospective 
cohort studies are key to study multiple risk factors and chronic diseases 
and are crucial to our understanding of the burden, aetiology and prognosis 
of NCDs in SSA. We aimed to identify the level of research output on NCDs 
and their risk factors collected by cohorts in SSA.
Methods We conducted a scoping review to map the extent of current NCDs 
research in SSA by identifying studies published after the year 2000 using 
prospectively collected cohort data on any of the six NCDs (cardiovascular 
diseases, diabetes, obesity, chronic kidney disease, chronic respiratory dis-
eases, and cancers), ≥1 major risk factor (other than age and sex), set only 
within SSA, enrolled ≥500 participants, and ≥12 months of follow-up with 
≥2 data collection points (or with plans to). We performed a systematic 
search of databases, a manual search of references lists from included arti-
cles and the INDEPTH network website, and study investigators from SSA 
were contacted for further articles.
Results We identified 30 cohort studies from the 101 included articles. 
Eighteen countries distributed in West, Central, East and Southern Afri-
ca, were represented. The majority (27%) set in South Africa. There were 
three studies including children, twenty with adults, and seven with both. 
53% of cohorts were sampled in general populations, 47% in clinical pop-
ulations, and 1 occupational cohort study. Hypertension (n = 23) was most 
commonly reported, followed by obesity (n = 16), diabetes (n = 15), CKD 
(n = 6), COPD (n = 2), cervical cancer (n = 3), and breast cancer (n = 1). The 
majority (n = 22) reported data on at least one demographic/environmental, 
lifestyle, or physiological risk factor but these data varied greatly.
Conclusions Most studies collected data on a combination of hyperten-
sion, diabetes, and obesity and few studies collected data on respiratory 
diseases and cancer. Although most collected data on different risk factors 
the methodologies varied greatly. Several methodological limitations were 
found including low recruitment rate, low retention rate, and lack of vali-
dated and standardized data collection. Our results could guide potential 
collaborations and maximize impact to improve our global understanding 
of NCDs (and their risk factors) in SSA and also to inform future research, 
as well as policies.
Electronic supplementary material: 
The online version of this article contains supplementary material.
journal of
health
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The pattern of disease occurrence in sub-Saharan Africa (SSA) is changing and 
the significance of chronic diseases is increasing [1]. Non-communicable dis-
eases (NCDs) cause a large and growing burden of death and disability in SSA; 
with regional hypertension prevalence of 48%, diabetes of 5.1%, and obesity of 
20% [2]. It is projected that they will overtake infectious diseases as major sourc-
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es of morbidity and mortality by 2030[3]. Presently, there is still opportunity to introduce measures that 
would reduce the burden of NCDs in SSA. Currently, SSA lacks adequate data and resources regarding 
NCDs to respond to this problem [3].
There is no reason to doubt that changes in lifestyle and unplanned, or unsustainable, urbanisation will 
have adverse health effects in SSA as in other regions. However, due to the combined effects of under-nu-
trition, infectious diseases, and other environmental factors, NCDs findings from other settings may not be 
applicable to this region. For example, infectious diseases such as HIV and tuberculosis have been shown 
to be risk factors for cardiovascular diseases and diabetes, in addition to early life malnutrition. The high 
prevalence of these potential risk factors in SSA might allow to shed light and understand better some of 
these associations [4]. There is a need for reliable data about the distribution of NCDs and known risk 
factors, how they change over time, and how risk factors relate to NCDs outcomes. With reliable data, it 
is possible to devise effective, long-term prevention strategies to combat disease burden.
Prospective cohort studies have traditionally been used to study multiple risk factors and complex dis-
eases and are crucial to our understanding of the aetiology and prognosis of NCDs within populations 
[5]. They can be used to study population-specific disease burden, genetic heterogeneity, and geographic 
and social diversity, which could prove to be novel risk factors. Large and well-designed cohort studies 
are essential for informing epidemiology, health services, and policies, as well as to stimulate health-pro-
moting change. Due to the limited funding for establishing NCD cohorts in SSA, it is important to map 
out existing cohorts for primary prevention and prognosis, of which the basis is surveillance and involves 
the systematic collection of high quality data [6].
Scoping reviews are used to map the extent of existing data available and to identify any gaps in the re-
search [7]. A scoping review from existing large cohorts of NCDs in SSA can answer what is known and 
what is not known in the region. This scoping review could extend the capacity of existing studies by syn-
thesizing ongoing research initiatives, facilitating consistency in data collection, and providing guidance on 
what further research would be a beneficial addition to the global understanding of NCDs in the region.
Previous reviews evaluated existing cohorts in SSA but, unlike our review, they were more limited in scope, 
focusing on either cardiovascular diseases, collection and storage of biological sample data, or on HIV/
AIDS patients after antiretroviral therapy (ART) [8-10]. In this scoping review, our main objective was to 
identify the level of research output on NCDs (cardiovascular disease, diabetes, obesity, respiratory dis-
ease, cancer, and chronic kidney disease), as well as their risk and prognostic factors, from large NCDs 
cohort studies in SSA. The final aim is to identify any limitations and gaps and inform future research.
METHODS
Eligibility criteria
Inclusion criteria
A. Study designs: Prospective cohort studies.
B. Study settings: Studies conducted within any SSA country.
C.  Study publication year: It has been shown that the almost flat number of publications per year in West 
African countries starts to slowly rise after 2000 and so we chose studies published from 2000 onwards 
[11]. This does not, however, pertain to when the studies were conducted.
D.  Study participants: There was no age limitation so that we were not restricted from looking across gen-
erations for clues to current patterns of health and disease; a life-course approach was taken.
E.  Study size: Studies with at least 500 participants.
F.  NCD data: We included studies which have collected data on at least one of the following NCDs: car-
diovascular disease (CVDs), type 2 diabetes, obesity, chronic respiratory diseases, cancer, and chronic 
kidney disease (CKD). Because some of these NCDs encompass a large number of diseases, we nar-
rowed our scope using expert opinion of SSA study investigators to the following: CVDs to hyperten-
sion; respiratory disease to asthma and chronic obstructive pulmonary disease (COPD); and cancers to 
breast, cervical, prostate, and oesophageal cancers.
G.  Study data collection points: We chose studies that collected NCD data at baseline and at least once 
more at follow-up.
Non-communicable diseases in sub-Saharan Africa
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H. Study follow-up: We included studies with a minimum of 12 months of follow-up. We also included 
studies that have just started and therefore do not yet have the follow up but have 12 months or more 
follow-up planned.
I. There was no language restriction.
Exclusion critEria
A. Studies conducted among populations of SSA origin but residing outside of SSA (eg, migrant studies).
B. Studies including a mixed population from inside and outside SSA.
C. Studies without at least one major risk factor other than sex and age measured at baseline.
Types of sources
Electronic sources
We systematically searched PubMed, MEDLINE, AfricaPortal, and SCOPUS databases, as well as per-
formed an informal search of Google Scholar, for studies published from 1 January 2000 to 1 March 2018. 
The electronic database search was conducted using a predefined comprehensive and sensitive search 
strategy in order to obtain the maximum possible number of studies.
Reference lists
We manually searched the reference lists of all relevant citations, as well as references quoted on the IN-
DEPTH network website [12], to identify further articles of interest.
Grey literature
We explored UK and US funded cohorts and cohort research databases (ie, UK Cohort Directory, LMIC 
LPS Directory, Birthcohorts.net, and Global Burden of disease).
Search strategy
For our search strategy, we used a modified four-step search strategy recommended for all Joanna Briggs 
Institute (JBI) review types [7,13]. The first step was an initial limited search of two of the online databases 
mentioned previously. From this search, we ascertained text words contained in the titles and abstracts of 
identified papers, as well as index terms used to describe the articles. We also sought input from a librarian 
to assist further with identifying MeSH headings and keywords pertinent to this study. Having identified 
keywords and index terms, a second search was performed across all included databases using these words. 
Table S1 in Online Supplementary Document presents the search terms used for MEDLINE; adapted 
in minor ways for other databases. The records were directly exported into a reference management soft-
ware to facilitate collaboration between investigators during the process. Duplicate records were excluded.
The search strategy was unable to distinguish between cross-sectional studies and cross-sectional analyses 
of cohort data. We were interested in the cohorts, rather than the published analyses. Two investigators 
(KM, MMJT) independently screened abstracts of records identified through database searching to ex-
clude articles analysing cross-sectional data only. Any inconsistencies or disagreements were resolved by 
consensus, or by consultation of a third author (PP), when resolution could not be achieved.
The third step was to obtain the full-text and assess articles for eligibility. When the full-text was unavail-
able, corresponding authors were contacted. Two investigators (KM, MMJT) independently selected ar-
ticles that met the inclusion criteria. Any articles that were excluded were listed separately, with reasons 
for their exclusion. Disagreements were resolved by consultation of a third author (PP). One investigator 
then manually searched the reference lists of articles identified through database searching.
The fourth and final step was unique to this review - we contacted study investigators from Health & 
Demographic Surveillance Systems (HDSSs) in SSA to help identify further cohort studies in West Africa 
(Benin, Burkina Faso, Ivory Coast, Guinea, Mali, Niger, Nigeria, Senegal, and Togo).
Data extraction
A data extraction form was developed and pre-piloted to ensure all relevant data were extracted (Table 
S2 in Online Supplementary Document). From the included articles, we identified individual cohort 
Mudie et al.
December 2019  •  Vol. 9 No. 2 •  020409 4 www.jogh.org •  doi: 10.7189/jogh.09.020409
V
IE
W
PO
IN
TS
PA
PE
RS
studies. For cohort studies with more than one identified article, the most recent and comprehensive 
publication was used [7]. Study characteristics extracted included country, design, start date, number 
of data collection points, and main focus (reason for its inception). The funding source of the study and 
whether the authors reported the potential to access the data was also collected. Data extracted relating 
to the design of the study included the following: sampling frame and method of sampling, inclusion/
exclusion criteria, number eligible, number enrolled, and sample size at final or most recent evaluation. 
The age, sex, ethnicity, and rural/urban location of participants were extracted, as well as any reported 
comparison groups.
Data collection of any of the pre-specified NCDs reported in any of the articles was extracted for each 
cohort study, regardless of the main focus. This included the definition of the disease status, the source 
of the measurement for diagnosing participants, and the number of time points the data were collected. 
How the authors reported the NCD (eg, prevalence, incidence, change), the estimate in the total sample, 
and any associated risk factors reported were also collected. All data extraction was evaluated for correct-
ness and completeness by a second reviewer.
We report studies based on the age group of the population and the type of population. Studies were 
grouped as ‘children’ or ‘adults’, as reported in the original publications, and ‘mixed’ if there was no age 
restriction. The type of populations included general, occupational, or clinical. We adapted the WHO 
STEPwise approach to the NCD risk factor surveillance framework to categorise the essential risk factors 
(Table 1). If the cohort collected data on any of these factors, the definition and source of each of their 
measurements were extracted.
Table 1. Definition of basic, core, or expanded classification within the four domains of risk factor data (adapted 
from WHO STEPwise [6])
Demographic & environmental influences lifestyle influences physiological influences
Basic Age, sex, rural/urban location Smoking status, alcohol use Height and weight, waist-circumference, bp, 
fasting/random blood glucose
Core Education, occupation,  
socio-economic status
Physical activity, diet Hip-circumference, lipids profile, urinalysis, 
infections (hiv, tb), anaemia
Expanded Indoor/outdoor pollution,  
occupational exposure
Sexual behaviour, breastfeed-
ing, age at menarche
Birthweight, body composition, oral glucose 
tolerance test, hba1c, genetics
BP – blood pressure, HbA1c – glycated hemoglobin
RESULTS
The database searches identified 7666 re-
cords, of which 2941 were duplicates (Fig-
ure 1). Through abstract screening, we 
excluded 4563 records mainly due to pub-
lication type (eg, letter), non-SSA setting, 
cross-sectional data, or non-human partic-
ipants. A further 89 articles were exclud-
ed after assessing the full-text and applying 
the eligibility criteria (Table S3 in Online 
Supplementary Document). We then 
added 28 articles from reference lists of in-
cluded articles, online databases, and SSA 
study investigators (four out of four inves-
tigators who were contacted responded) to 
give a total of 101 articles included in this 
review. From these, we identified 30 co-
hort studies meeting our eligibility criteria; 
20 identified through the database search, 
6 identified through reference lists, and 2 
identified through SSA study investigators.Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) flow diagram for study selection process.
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Study characteristics
The study characteristics are reported in Table 2 and in detail in Tables S4a-d in Online Supplementa-
ry Document. The majority (27%) of the studies were conducted in South Africa, followed by Uganda 
(20%), Nigeria (13%), and the Democratic Republic of Congo (7%) (Figure 2).
Three studies were set across multiple SSA countries and seven studies were set in a West African coun-
try. The country with the most number of participants enrolled within these studies was South Africa 
(n = 51 263). Study duration (from recruitment to the end of follow-up) ranged from one year to 38 years 
with a median of four and a half years (IQR = 2.3-11). Thirteen of the included studies reported the po-
tential to access raw data in a published article while fifteen did not report this and two reported no ac-
cess. The Birth to Twenty (BT20) study reported the collection and storage of 2200 child samples, along 
with 2200 samples from one parent. One study reporting cervical cancer data also reported stored cervi-
cal samples (both smears and biopsies).
Table 2. Characteristics of included 
studies, including the countries repre-
sented, study designs, and duration of 
each, as well as whether potential to 
access data was reported and types of 
stored samples (N = 30)
characteristics n (%)
Countries represented*
Benin 2 (7)
Burkina Faso 2 (7)
Democratic Republic of Congo 2 (7)
Gambia 1 (3)
Ghana 2 (7)
Kenya 1 (3)
Lesotho 1 (3)
Malawi 1 (3)
Mauritius 1 (3)
Namibia 1 (3)
Nigeria 4 (13)
Rwanda 1 (3)
Seychelles 1 (3)
South Africa 8 (27)
Sudan 1 (3)
Tanzania 1 (3)
Uganda 6 (20)
Zambia 2 (7)
Study duration (years)
1-2 8 (27)
3-5 9 (30)
6-10 3 (10)
>10 10 (33)
Potential to access data?
Yes 13 (43)
No 2 (7)
Not reported 15 (50)
Stored samples:
DNA 3 (10)
Blood 1 (3)
Tumour 2 (7)
Serum 1 (3)
*Number of countries is greater than 30 as 
some studies (N = 3) are set in more than 
one country, details found in Table S3 in 
Online Supplementary Document.
Figure 2. Map of non-communicable disease (NCD) cohorts 
found in SSA countries.
Participant characteristics
Just over half of the cohorts were in general population (53%) followed by clinical 
population (47%). There was only one occupational cohort study found, which 
focused on the health of Basotho gold miners in Lesotho (Table 3, Table S5a-d in 
the Online Supplementary Document). Of the general cohort studies, two were 
birth cohorts – one set in South Africa and the other in Malawi. The number of 
participants enrolled in each study ranged from 500 participants in the Uganda 
AIDS Rural Treatment (UARTO) Cohort to over 33 000 participants in the Rakai 
Community Cohort Study (RCCS) with a median of 2258 participants (IQR = 955-
6102) altogether.
The age of participants from all included studies ranged from birth to 95 years. 
There were three studies including children and young people aged 20 years or 
less, seven studies including both children and adults, and twenty studies includ-
ing adults aged 18 years or more. Stratifying on age group, the median number 
enrolled among the child studies, mixed studies, and adult studies was 779, 5563, 
and 2045 participants, respectively. The majority (n = 21) of studies included both 
males and females at a roughly even ratio. Eight studies were set in rural locations, 
five in urban locations, and seven in mixed rural and urban locations. Rural/urban 
location was not reported in 10 (33%) of studies.
NCD data
Hypertension was the most common NCD reported on (n = 23), followed by obe-
sity (n = 16) and diabetes (n = 15) (Table 4, Table S6a-d in Online Supplementary 
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Document). There were very few studies collecting data on COPD and we did 
not find any studies collecting data on asthma that met our eligibility criteria. 
Out of the pre-specified cancers, we only found studies reporting on cervi-
cal (n = 3) and breast (n = 1) cancers that met the criteria. Half of the studies 
(50%) reported the collection of three or more chronic NCDs. The majority of 
studies included data on hypertension, as well as diabetes and obesity. There 
were four studies that collected data on only biomarkers for CKD. Two stud-
ies, the Africa Wits-INDEPTH partnership for Genomic (AWI-Gen) Studies 
(with more than 10 000 participants) and the African Breast Cancer Dispar-
ities in Outcomes (ABC-DO) Study (with nearly 2000 participants), collect-
ed data on five of the six NCDs. In general, the NCD data collected by these 
studies were objectively measured for the purpose of the study.
Risk factor data
The characteristics of risk factor data collected by included studies varied 
greatly (Figure 3) and are presented in greater detail in Appendix Table 6a-
e. The majority (n = 22) of studies reported the collection of data on at least 
one demographic/environmental, lifestyle, or physiological risk factor. There 
were two studies, the Birth to Twenty cohort (BT20) and the ACCME’s HPV 
and Cervical Cancer Study, which reported the collection of almost all the 
pre-specified basic, core, and expanded risk factors in each category. One 
study, the prospective cohort in Sudan, only reported physiological risk factor 
data; it did not include data such as rural/urban location or smoking status. 
Environmental data were collected by only three studies – both the General 
Population Cohort (GPC) and the RCCS reported data on aflatoxin exposure 
and the Basotho Gold Miners Cohort reported data on silica dust exposure.
Methodological characteristics
Out of all the included studies, 37% (n = 11) utilised random sampling of 
participants, 53% (n = 16) utilised a convenience sample and 10% (n = 3) did 
not report sampling method. There was a total of 11 studies that enrolled 
more than 80% of eligible participants (2 child studies, 3 mixed studies, and 
6 adult studies), while 10 studies were unclear or did not report the number 
of participants who were eligible to participate. 43% (n = 13) of the includ-
ed studies were able to follow-up at least 70% of their enrolled participants, 
40% (n = 12) were unclear or did not report the number of participants fol-
lowed up, and two studies (AWI-Gen and HAALSI) had not yet completed 
its first round of follow-up. The majority (87%) of studies – all 3 child stud-
ies, all 7 mixed studies, and 16 adult studies - collected NCD data objectively 
for the purpose of the study. These studies also reported either using validat-
ed or standardised methods (n = 11), checking their methods against a ‘gold 
standard’ (n = 2), or calibrating equipment (n = 4). Demographic and lifestyle 
risk factor data was self-reported in these studies, however, many used stan-
dardised questionnaires such as the WHO STEPwise questionnaire, making 
the data comparable to other studies. Physiological risk factor data was objec-
tively measured in 63% of included studies, obtained from medical records 
in 7%, and not reported in 10%.
DISCUSSION
Main findings
Our comprehensive search strategy identified 30 studies (reported in 101 pa-
pers) prospectively collecting longitudinal data on NCDs and their risk/prog-
nostic factors within SSA. Eighteen countries, out of the fifty countries in SSA, 
were represented among the included studies, in the West, East, Central and 
Table 3. Characteristics of participants 
within included studies, including sam-
pling frame, number enrolled, age groups 
reported, sex(s) included, and wheth-
er rural/urban location was reported 
(N = 30)
characteristics n(%)
Sampling frame:
General population 16 (53)
Occupational population 1 (3)
Clinical population 13 (43)
Number enrolled:
500-999 9 (30)
1000-4999 11 (37)
5000-10 000 4 (13)
>10 000 6 (20)
Age groups:
Children 3 (10)
Mixed 7 (23)
Adults 20 (67)
Sex(s) included:
Males only 2 (7)
Females only 7 (23)
Mixed 21 (70)
Rural/urban location:
Rural only 8 (27)
Urban only 5 (17)
Mixed 7 (23)
Not reported 10 (33)
Table 4. NCD data characteristics includ-
ing total number of studies reporting 
each and percentage of each NCD re-
ported in terms of prevalence, incidence, 
change in mean, or not reported (N = 30)
characteristics n (%)
NCDs*
Hypertension 23 (77)
Diabetes 15 (50)
Obesity 18 (60)
CKD 6 (20)
COPD 2 (7)
Breast cancer 1 (3)
Cervical cancer 3 (10)
Prostate cancer 0 (0)
Oesophageal cancer 0 (0)
Number of NCDs studied in each:
1 12 (40)
2 3 (10)
≥3 15 (50)
Reporting of NCD:
Aetiology (prevalence) 19 (63)
Incidence 3 (10)
Prognosis (change) 4 (13)
Not reported 4 (13)
NCD – non-communicable diseases
*Number of NCDs reported on is greater than 
30 as some studies collected data on more than 
one NCD.
Non-communicable diseases in sub-Saharan Africa
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Southern Africa with the majority set in South Africa. The total number of participants under study was 
highest in South Africa, followed by Uganda and Zambia. There were three studies that reported includ-
ing only children and young people under the age of 20 years and seven studies that reported including 
both children and adults.
Regardless of their main focus, the majority of studies collected data on a combination of hypertension, 
diabetes, and obesity. These studies also collected robust risk factor data. Of the six studies that report-
ed the collection of CKD data, half reported collecting additional data on at least hypertension; a closely 
associated risk factor. COPD is the third leading cause of death worldwide, and little is known about the 
prevalence in SSA [14]. The two clinical studies collecting COPD data reported few risk factor data. Many 
cross-sectional studies with asthma data were found during the selection processes, but we did not find 
one cohort study meeting the eligibility criteria. Breast and cervical cancers are the two leading causes of 
cancer mortality among women in SSA, with shifts in risk factors often providing the only indications for 
prevention programmes [15]. Three studies reported breast or cervical cancer data and included limited 
risk factor data. The burden of prostate and oesophageal cancers in SSA is also unclear, reflected by the 
lack of data found.
Less than half of the included studies enrolled more than 80% of eligible participants or were able to fol-
low-up more than 70% of enrolled participants. This highlights some methodological challenges faced 
when conducting these studies that should be considered for future studies. We found that NCD data 
and risk factor data were objectively measured for the purpose of the study in the majority of the includ-
ed studies. Most of this data was measured using validated measures or standard procedures.
The main strengths of our review are the wide scope of diseases and the inclusion of studies with large 
numbers of participants. Similar reviews of existing cohorts in SSA have been carried out but were limited 
Figure 3. Risk factor data reported in each study categorised into demographic and environmental (D&E), lifestyle 
(L), and physiological (P) risk factors. A white (or empty) circle represents the absence of basic (outside circle), core 
(middle), or expanded (inside) level of risk factor data, and a coloured circle represents the presence of basic (orange), 
core (yellow), or expanded (green) level of risk factor data. D&E – Demographic & environmental risk factor data; L 
– Lifestyle risk factor data; P – Physiological risk factor data; CKD – chronic kidney disease; COPD – chronic obstruc-
tive pulmonary disease; CC – cervical cancer; BC – breast cancer; ACCME – African Collaborative Centre for Microbi-
ome and Genomics Research; HAALSI – Health & Aging in Africa – Longitudinal Studies of INDEPTH Communities; 
NCD – non-communicable diseases; DUCS-HTN – the Dar es Salaam Urban Cohort Hypertension study; ABC-DO – 
African Breast Cancer – Disparities in Outcomes study; HARP – HPV in Africa Research Partnership; CoLTART – the 
Complications of Long-Term Antiretroviral Therapy study; RWISA – Rwanda Women’s Interassociation Study and As-
sessment; UARTO – Uganda AIDS Rural Treatment Outcomes study.
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in scope. One study was a systematic review of birth cohorts, including only participants at less than 10 
years of age at enrolment [9]. Another two studies included cohorts with very few participants [10,16]. 
Unlike these reviews, ours is a comprehensive review of the cohort studies from articles published after 
the year 2000 covering all ages, four different regions and a wide range of NCDs, providing a useful re-
source for assessing the available evidence in SSA.
Although we used a systematic approach to search for eligible studies and did not limit our eligibility by 
any specific funder, it is possible that our review is at risk of publication bias. There may be cohorts of 
participants under study in these populations collecting data on NCDs that we were not able to capture 
because the data has not been published or has been published in grey literature, such as PhD theses. In 
addition, almost all of the published articles found were in English, with a few in French or Portuguese. 
It is likely that more non-English articles exist but were not found in the database searches because they 
lack international readership. To overcome this, we specifically contacted study investigators from Fran-
cophone West Africa in order to reduce publication bias. As any review of published studies our study 
might have been affected by reporting bias because it was only possible to extract data that has been pub-
lished, but some studies might have not reported all the relevant information.
CONCLUSION
Scoping reviews are a useful tool to map existing data available and to identify any gaps in research. 
In this scoping review, we presented the existing data on six NCDs, and their risk factors, which has 
been collected by large cohort studies in SSA. In terms of the total number of studies, regardless of 
their main focus, most of the existing data available were on hypertension, followed by diabetes and 
obesity, which is probably due to the relative ease of data collection and possibly a higher prevalence of 
these conditions. In terms of the total number of participants reporting biomarkers, most of the exist-
ing data available were on biomarkers of CKD. Very few data were available for COPD, and the studies 
collecting this data utilised self-report or invalid methods. Existing data was available for breast and 
cervical cancers but not for prostate or oesophageal. Risk factor data available varied widely and was 
not always clearly-reported.
Implications
To the best of our knowledge this is the first time NCD cohorts in SSA have been mapped out, provid-
ing key visibility to researchers, both locally and internationally, to identify areas for collaboration and 
further interrogation. This is especially important when Africa is experiencing both a demographic tran-
sition with an ageing population and an epidemiological transition with an increased number of NCD. 
Our findings showed that currently most cohorts are focused on a specific NCD with few addressing a 
combination of NCDs, or their shared risk factors. We hope that the finding that multi-morbidity is not 
properly included in this type of cohorts will call the attention of interested researchers and new cohorts 
of NCD will be designed to include this increasingly phenomenon in adults and older population. There 
is also a lack of standardized methodology and important limitations regarding sampling and follow up 
of participants, which may require clear and standardised international guidelines. Furthermore, only half 
of the cohorts were in the general population. This is particularly relevant for SSA where, compared to 
other regions, people have lower accessibility to health services and many people are not aware of their 
chronic conditions. In order to better understand the epidemiology of NCDs, including aspects related 
to aetiology, burden and prognosis, we need large population studies across different countries and de-
mographic groups, with adequate sampling, long-term follow-up, detailed phenotyping and standardised 
assessments of NCDs and their risk factors.
One exemplar of this type of initiative is the recently funded African NCD Longitudinal Data Alliance 
(ANDLA) which brings together data currently from eight population-based cohorts from five countries 
across sub-Saharan Africa to create large, harmonised data sets that are robust and powerful enough to 
address important research questions with generalizable findings that partners could not address individ-
ually. ANDLA will provide a dynamic and sustainable platform of population-based data collected over 
time (longitudinal-data). The data will be standardised and made available in an easily usable form and 
will focus on NCD and their risk factors. It will be a unique large-scale data resource for understanding 
NCD in Africa to inform and shape effective policy. Our review can also be useful to flag important knowl-
edge gaps that need addressing by initiatives such as ANDLA.
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The key to the control of the NCD epidemic in SSA is primary prevention and prognosis, the basis 
of which is surveillance and involves the systematic collection of high quality data [6]. This informa-
tion is essential for advising future research, as well as public health policies. There are many studies 
collecting high quality data that could easily be built upon to include the full range of NCDs. These 
studies could be useful to study the life-course approach to NCDs and their interaction. In addition, 
more than half of the included studies were sampled from the general population, which can be useful 
for designing local policies. The large Network of Health and Demographic Surveillance System sites 
(HDSS) distributed along SSA, provides a longitudinal demographic platform where researchers can 
design large population-based studies for chronic conditions in a well stablished research environment. 
This is the case, for example of the Health and Aging in Africa: a longitudinal study of an INDEPTH 
community (HAALSI).
Highlighting the importance of the existing cohorts could be used by researchers to leverage addition-
al funding from local policy makers to extend, expand, or enrich their current research platforms. For 
policy makers this manuscript showcases the cohorts that could be used to identify locally relevant out-
comes which in turn could shape, or target, future interventions. For policy makers this manuscript also 
provides clarity on existing cohort gaps, providing an opportunity for funding to be directed in the most 
impactful direction.
Groups like the Coalition for African Research Innovation (CARI) [17] have exposed the bias in SSA 
research funding towards the infectious disease space. Given the current limitations in funding avail-
able for NCD research in SSA, mapping out and understanding infectious disease cohorts that could 
lend themselves to study NCDs or their interaction, would be a logical future step to complement the 
current report. This is particularly important given the emergence of ID/NCD dual disease burden in 
LMICs. Knowledge of the existing NCD cohort environment would enable both funders and research-
ers to readdress this bias.
Regarding some of the methodological challenges, future studies should consider design strategies, like 
using health tools and wearables that could facilitate consistency in data collection to ensure consistent 
and comparable data. Also, better communication and coordination between the different research groups 
could be beneficial to explore potential collaborations to maximize the impact of each study improve our 
global understanding of chronic NCDs, and their risk factors, in SSA.
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